Filing Details
- Accession Number:
- 0001638599-17-000668
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-30 16:33:56
- Reporting Period:
- 2017-06-29
- Filing Date:
- 2017-06-30
- Accepted Time:
- 2017-06-30 16:33:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1453687 | Selecta Biosciences Inc | SELB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1676906 | David Siewers | C/O Selecta Biosciences, Inc. 480 Arsenal Way Watertown MA 02472 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-06-29 | 3,846 | $0.47 | 3,882 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-06-29 | 5,770 | $0.63 | 9,652 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-29 | 9,616 | $20.00 | 36 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-29 | 36 | $20.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2017-06-29 | 3,846 | $0.00 | 3,846 | $0.47 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2017-06-29 | 5,770 | $0.00 | 5,770 | $0.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-09-19 | No | 4 | M | Direct | |
| 9,614 | 2020-09-06 | No | 4 | M | Direct |
Footnotes
- The transactions reported for the 3,846 shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.
- The transactions reported for the 5,770 shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.01, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the set forth herein.
- The 36 shares sold were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2016.
- All shares underlying this option are fully vested.
Billionaire Hedge Funds
